Ever because the Christian Democratic Union (CDU) grew to become the biggest occasion in Germany’s ruling coalition authorities in February 2025, the nation’s booming hashish trade has been bracing for a crackdown.
Even earlier than the election, when the CDU regarded prone to capitalise on the political chaos that had preceded its eventual inauguration, the occasion made its intentions to roll again the lately enacted CanG act as quickly because it entered the Bundestag.
In its election manifesto, the CDU/CSU pledged to ‘abolish the earlier authorities’s hashish regulation,’ stating that it ‘protects sellers and exposes our kids and younger individuals to drug use and habit’, and its anti-CanG rhetoric predictably accelerated as soon as the outcomes had been formalised.
Legislative efforts to make good on their threats and reverse lots of the adjustments which have enabled Germany’s medical hashish market’s speedy enlargement are nonetheless in course of.
Following months of inaction, seemingly immovable boundaries to implementation from its coalition companions within the SPD, and hundreds of thousands of Euros flowing into the trade from internationally, the CDU’s die-hard place could also be starting to shift.
Germany’s ever-shifting hashish market, the optimistic examples of pilot trials in Switzerland and the Netherlands, and the impression of all these elements on the broader European trade will probably be explored intimately on the European Hashish Insights Summit in Berlin later this month. Be part of 200 hashish leaders for the half-day, data-rich occasion, and get your palms on actionable proprietary market information from Prohibition Companions.
Streeck breaks rank
Final month, throughout an interview with RedaktionsNetzwerk Deutschland , Germany’s Federal Drug Commissioner Dr Hendrik Streeck mentioned he can be ‘personally open’ to the long-anticipated adult-use hashish pilot tasks.
The pilot tasks, a part of so-called ‘Pillar 2’ in Germany’s unique CanG act, have all however been forgotten as consideration has targeted on the largely sudden explosion within the medical market.
The place Pillar 1 legalised residence cultivation and non-commercial hashish social golf equipment, alongside making basic adjustments to the medical framework beneath MedCanG, Pillar 2 was geared toward exploring a business adult-use framework.
Though nonetheless a far cry from its preliminary plans for Canada-style absolutely regulated legalisation, Pillar 2’s pilot tasks promised licensed specialist outlets promoting hashish to adults, underpinned by regulated home manufacturing and wholesale provide chains. The framework was designed to be scientifically evaluated over 5 years, producing information on public well being outcomes, youth entry, and the impression on the black market earlier than any choice on everlasting commercialisation.
Politics, as ever, obtained in the way in which of Pillar 2 being enacted. The traffic-light coalition, which pushed CanG over the road, enacted Pillar 1 however ran out of time earlier than Pillar 2 could possibly be legislated, leaving it as an intention on paper fairly than regulation.
With the CDU promising a dramatic swing backwards, the pilot tasks had been broadly assumed to be a misplaced trigger.
Now, in an obvious concession to the overwhelming demand from the German inhabitants, has signalled a possible willingness to resurrect the undertaking.
Recognising that round 5 million Germans now commonly devour hashish, Streeck advised RND: “We can not ignore that. It’s no use both sugarcoating a regulation or pretending that we will merely reverse the development with out contemplating the truth.”
The German Hashish Enterprise Affiliation (BvCW) welcomed Streeck’s intervention, noting that a number of BvCW member corporations have already submitted mannequin undertaking proposals to the Federal Workplace for Agriculture and Meals (BLE).
“Profitable pilot tasks in neighbouring European international locations like Switzerland and the Netherlands have already demonstrated that such scientific endeavours perform easily in follow,” the affiliation mentioned in a press release.
Echoing the trade’s frustrations with the present framework, Steeck added: “If cultivation associations are regulated in such an advanced method that they barely perform, there is no such thing as a management, however fairly evasive habits, then we have to have an trustworthy dialogue about simplification.
“Those that want hashish for medical functions should proceed to obtain it. However the medical route should not develop into an alternative choice to leisure use. We have to draw a clearer line between the 2,”
This, nevertheless, was removed from outright advocacy. Streeck caveated his willingness to discover pilot tasks, stating that these must be closely restricted: “No normalisation, no business enlargement, no promoting, no distribution to younger adults. Very restricted portions can be conceivable, round 5 grams, distribution solely to individuals over 25, and shut scientific monitoring.”
Alex Khourdaji, Lead Analyst at Prohibition Companions, advised MEDCAN24: “Germany’s Federal Drug Commissioner, Dr Hendrik Streeck’s place on Pillar 2 development, is a breath of recent air, hopefully that use of air will materialise to precise progress.
“The optimistic outcomes of pilot tasks in Switzerland and the Netherlands have positively influenced the discourse on hashish legalisation within the area. Highlighting the significance of scientific trials and information in additional evolving the trade. Moreover, following the growth of the medical hashish market, I reckon the German authorities is starting to just accept that there’s a massive client base in Germany and that legalisation with taxation may need a optimistic financial impression”
READ MORE…
What’s taking place within the medical market?
Regardless of dropping momentum in its efforts to reverse the adjustments to the MedCanG invoice, which eliminated medical hashish from the checklist of narcotic substances and cleared the trail for the speedy development seen since April 2024, the CDU’s issues are usually not purely partisan.
Warning surrounding the blurring of concrete traces between the medical and leisure markets is shared extra broadly all through the coalition, and even inside some outstanding trade gamers.
In accordance with Germany’s Federal Institute for Medicine and Medical Gadgets (BfArM), overlaying Q1 2026, Germany imported 50,539 kg of hashish flower in Q1 2026, marking a 16.8% fall on This fall 2025’s 60,772 kg, and the primary quarterly decline because the CanG took impact in April 2024.
Q1 2026 — hashish flower imports by provider nation (kg)
Supply: BfArM tabular import information, Q1 2026 launch (Might 2026). Hashish flowers solely.
That drop follows a 12 months during which flower imports totalled 205,241 kg, up from 72,850 kg in 2024. BfArM itself notes that “though import declarations have to be submitted instantly by regulation, occasional delays or subsequent corrections could happen”, that means the Q1 determine could but be revised.
Regardless of indicators of a possible slowing of development, Q1 2026 imports had been nonetheless round 34% greater than Q1 2025’s 37,686 kg. Canada, which equipped 26,753 kg in Q1 2026, remained the dominant exporter at 53% of the entire, remaining primarily flat quarter-on-quarter.
The decline was concentrated in different main exporters. Portugal fell 21% to 10,342 kg, Australia dropped 65%, and Malta’s exports collapsed 95% from This fall’s 1,772 kg to simply 95 kg. Denmark was the notable exception, rising 61% to three,338 kg.
A ‘brutal concept’
In accordance with the CDU, a key indicator of the overlap between medical and leisure utilization is the divergence between prescriptions paid for instantly by sufferers and people reimbursed beneath statutory medical insurance (Gesetzliche Krankenversicherung, or GKV).
Streeck famous that whole medical hashish imports rose 170% between the primary and second half of 2024, whereas prescriptions coated by statutory medical insurance grew solely 9%. Well being Minister Nina Warken (CDU) attributes the hole on to on-line platforms getting used as a backdoor to leisure provide.
GKV reimbursed €249m in hashish spending within the full-year 2025, with dried flower the one largest class at €125m.
In March 2026, the Finance Fee for Well being advisable eradicating flower from the GKV advantages catalogue totally. Standardised extracts and authorized completed medicines akin to dronabinol and nabilone would stay reimbursable; flower would develop into a self-pay merchandise. The fee estimates financial savings of round €130m in 2027, rising to €180m by 2030.
The Affiliation of Hashish-Allotting Pharmacies (VCA) and the German Affiliation of the Pharmaceutical Hashish Business (BPC) have each rejected the advice, warning that eradicating reimbursement would drive sufferers off remedy or towards uncontrolled provide.
Though the advice shouldn’t be but regulation, Dirk Heitepriem, President of the German Hashish Enterprise Affiliation (BvCW), advised delegates at Hashish Europa London final week: “That’s an assault on the actually, actually ailing individuals. “We’re transferring from ‘we don’t like potential leisure customers coming into the medical market’ to ‘we’ll take away the reimbursement from people who find themselves genuinely sick.’ That could be a brutal concept.”
His continued: “The stronger the trade represents itself as one voice, the higher. Be part of your trade associations, work with affected person teams, with medical doctors, and with pharmacies. Construct widespread positions. That’s the solely method this works.”
Ever because the Christian Democratic Union (CDU) grew to become the biggest occasion in Germany’s ruling coalition authorities in February 2025, the nation’s booming hashish trade has been bracing for a crackdown.
Even earlier than the election, when the CDU regarded prone to capitalise on the political chaos that had preceded its eventual inauguration, the occasion made its intentions to roll again the lately enacted CanG act as quickly because it entered the Bundestag.
In its election manifesto, the CDU/CSU pledged to ‘abolish the earlier authorities’s hashish regulation,’ stating that it ‘protects sellers and exposes our kids and younger individuals to drug use and habit’, and its anti-CanG rhetoric predictably accelerated as soon as the outcomes had been formalised.
Legislative efforts to make good on their threats and reverse lots of the adjustments which have enabled Germany’s medical hashish market’s speedy enlargement are nonetheless in course of.
Following months of inaction, seemingly immovable boundaries to implementation from its coalition companions within the SPD, and hundreds of thousands of Euros flowing into the trade from internationally, the CDU’s die-hard place could also be starting to shift.
Germany’s ever-shifting hashish market, the optimistic examples of pilot trials in Switzerland and the Netherlands, and the impression of all these elements on the broader European trade will probably be explored intimately on the European Hashish Insights Summit in Berlin later this month. Be part of 200 hashish leaders for the half-day, data-rich occasion, and get your palms on actionable proprietary market information from Prohibition Companions.
Streeck breaks rank
Final month, throughout an interview with RedaktionsNetzwerk Deutschland , Germany’s Federal Drug Commissioner Dr Hendrik Streeck mentioned he can be ‘personally open’ to the long-anticipated adult-use hashish pilot tasks.
The pilot tasks, a part of so-called ‘Pillar 2’ in Germany’s unique CanG act, have all however been forgotten as consideration has targeted on the largely sudden explosion within the medical market.
The place Pillar 1 legalised residence cultivation and non-commercial hashish social golf equipment, alongside making basic adjustments to the medical framework beneath MedCanG, Pillar 2 was geared toward exploring a business adult-use framework.
Though nonetheless a far cry from its preliminary plans for Canada-style absolutely regulated legalisation, Pillar 2’s pilot tasks promised licensed specialist outlets promoting hashish to adults, underpinned by regulated home manufacturing and wholesale provide chains. The framework was designed to be scientifically evaluated over 5 years, producing information on public well being outcomes, youth entry, and the impression on the black market earlier than any choice on everlasting commercialisation.
Politics, as ever, obtained in the way in which of Pillar 2 being enacted. The traffic-light coalition, which pushed CanG over the road, enacted Pillar 1 however ran out of time earlier than Pillar 2 could possibly be legislated, leaving it as an intention on paper fairly than regulation.
With the CDU promising a dramatic swing backwards, the pilot tasks had been broadly assumed to be a misplaced trigger.
Now, in an obvious concession to the overwhelming demand from the German inhabitants, has signalled a possible willingness to resurrect the undertaking.
Recognising that round 5 million Germans now commonly devour hashish, Streeck advised RND: “We can not ignore that. It’s no use both sugarcoating a regulation or pretending that we will merely reverse the development with out contemplating the truth.”
The German Hashish Enterprise Affiliation (BvCW) welcomed Streeck’s intervention, noting that a number of BvCW member corporations have already submitted mannequin undertaking proposals to the Federal Workplace for Agriculture and Meals (BLE).
“Profitable pilot tasks in neighbouring European international locations like Switzerland and the Netherlands have already demonstrated that such scientific endeavours perform easily in follow,” the affiliation mentioned in a press release.
Echoing the trade’s frustrations with the present framework, Steeck added: “If cultivation associations are regulated in such an advanced method that they barely perform, there is no such thing as a management, however fairly evasive habits, then we have to have an trustworthy dialogue about simplification.
“Those that want hashish for medical functions should proceed to obtain it. However the medical route should not develop into an alternative choice to leisure use. We have to draw a clearer line between the 2,”
This, nevertheless, was removed from outright advocacy. Streeck caveated his willingness to discover pilot tasks, stating that these must be closely restricted: “No normalisation, no business enlargement, no promoting, no distribution to younger adults. Very restricted portions can be conceivable, round 5 grams, distribution solely to individuals over 25, and shut scientific monitoring.”
Alex Khourdaji, Lead Analyst at Prohibition Companions, advised MEDCAN24: “Germany’s Federal Drug Commissioner, Dr Hendrik Streeck’s place on Pillar 2 development, is a breath of recent air, hopefully that use of air will materialise to precise progress.
“The optimistic outcomes of pilot tasks in Switzerland and the Netherlands have positively influenced the discourse on hashish legalisation within the area. Highlighting the significance of scientific trials and information in additional evolving the trade. Moreover, following the growth of the medical hashish market, I reckon the German authorities is starting to just accept that there’s a massive client base in Germany and that legalisation with taxation may need a optimistic financial impression”
READ MORE…
What’s taking place within the medical market?
Regardless of dropping momentum in its efforts to reverse the adjustments to the MedCanG invoice, which eliminated medical hashish from the checklist of narcotic substances and cleared the trail for the speedy development seen since April 2024, the CDU’s issues are usually not purely partisan.
Warning surrounding the blurring of concrete traces between the medical and leisure markets is shared extra broadly all through the coalition, and even inside some outstanding trade gamers.
In accordance with Germany’s Federal Institute for Medicine and Medical Gadgets (BfArM), overlaying Q1 2026, Germany imported 50,539 kg of hashish flower in Q1 2026, marking a 16.8% fall on This fall 2025’s 60,772 kg, and the primary quarterly decline because the CanG took impact in April 2024.
Q1 2026 — hashish flower imports by provider nation (kg)
Supply: BfArM tabular import information, Q1 2026 launch (Might 2026). Hashish flowers solely.
That drop follows a 12 months during which flower imports totalled 205,241 kg, up from 72,850 kg in 2024. BfArM itself notes that “though import declarations have to be submitted instantly by regulation, occasional delays or subsequent corrections could happen”, that means the Q1 determine could but be revised.
Regardless of indicators of a possible slowing of development, Q1 2026 imports had been nonetheless round 34% greater than Q1 2025’s 37,686 kg. Canada, which equipped 26,753 kg in Q1 2026, remained the dominant exporter at 53% of the entire, remaining primarily flat quarter-on-quarter.
The decline was concentrated in different main exporters. Portugal fell 21% to 10,342 kg, Australia dropped 65%, and Malta’s exports collapsed 95% from This fall’s 1,772 kg to simply 95 kg. Denmark was the notable exception, rising 61% to three,338 kg.
A ‘brutal concept’
In accordance with the CDU, a key indicator of the overlap between medical and leisure utilization is the divergence between prescriptions paid for instantly by sufferers and people reimbursed beneath statutory medical insurance (Gesetzliche Krankenversicherung, or GKV).
Streeck famous that whole medical hashish imports rose 170% between the primary and second half of 2024, whereas prescriptions coated by statutory medical insurance grew solely 9%. Well being Minister Nina Warken (CDU) attributes the hole on to on-line platforms getting used as a backdoor to leisure provide.
GKV reimbursed €249m in hashish spending within the full-year 2025, with dried flower the one largest class at €125m.
In March 2026, the Finance Fee for Well being advisable eradicating flower from the GKV advantages catalogue totally. Standardised extracts and authorized completed medicines akin to dronabinol and nabilone would stay reimbursable; flower would develop into a self-pay merchandise. The fee estimates financial savings of round €130m in 2027, rising to €180m by 2030.
The Affiliation of Hashish-Allotting Pharmacies (VCA) and the German Affiliation of the Pharmaceutical Hashish Business (BPC) have each rejected the advice, warning that eradicating reimbursement would drive sufferers off remedy or towards uncontrolled provide.
Though the advice shouldn’t be but regulation, Dirk Heitepriem, President of the German Hashish Enterprise Affiliation (BvCW), advised delegates at Hashish Europa London final week: “That’s an assault on the actually, actually ailing individuals. “We’re transferring from ‘we don’t like potential leisure customers coming into the medical market’ to ‘we’ll take away the reimbursement from people who find themselves genuinely sick.’ That could be a brutal concept.”
His continued: “The stronger the trade represents itself as one voice, the higher. Be part of your trade associations, work with affected person teams, with medical doctors, and with pharmacies. Construct widespread positions. That’s the solely method this works.”
Hashish Regulation Assets in Poland
Discover important authorized pages about hashish cultivation, gross sales, and medical product rules in Poland. These assets will information you thru permissions, certifications, and compliance necessities.
-
Polish News Registration and Interests of Cannabis Businesses
-
Permissions for Cannabis Sales in Poland
-
Authorization for Importing or Manufacturing Medical Products
-
Permission for Manufacturing or Importing Medical Products
-
Certificate of Good Manufacturing Practices (GMP)
-
Registration of Medical Products in Poland